Powder: -20°C for 3 years | In solvent: -80°C for 1 year
GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
2 mg | 約 5 days | ¥ 20,000 |
5 mg | 約 5 days | ¥ 32,500 |
1 mL * 10 mM (in DMSO) | 約 5 days | ¥ 30,500 |
説明 | GSK180 is a selective competitive inhibitor of kynurenine 3-monooxygenase (KMO; IC50: ~6 nM), an enzyme involved in tryptophan metabolism. |
ターゲット&IC50 | KMO:~6 nM |
In vitro | GSK180 inhibits endogenous KMO activity in primary human hepatocytes (IC50=2.6 μM) and it also inhibits rat KMO slightly less potently than the human enzyme (IC50=7 μM). |
In vivo | GSK180 is fit for i.v. management [1]. |
分子量 | 276.07 |
分子式 | C10H7Cl2NO4 |
CAS No. | 1799725-26-0 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
GSK180 1799725-26-0 Metabolism Hydroxylase GSK 180 GSK-180 Inhibitor inhibitor inhibit